Join us for the 7th annual Advancing Excellence in Transgender Health Conference!
This years' conference will take place virtually October 1st-3rd, 2021.
Transgender people who have access to gender-affirming surgery report better mental health outcomes, according to a new study. The report, published Wednesday in JAMA Surgery, compared the psychological distress levels, suicide risk and substance use in transgender and gender diverse people who had undergone gender-affirming surgery with those who wanted such procedures but had not yet had them. “This study adds to a growing body of evidence showing affirmation in all forms can be life-saving for trans and gender-diverse people,” said lead author Anthony Almazan, a fourth-year medical student at Harvard Medical School. “Policies that limit access to care can put lives at risk. Our evidence shows we should be expanding gender-affirming care, not limiting it.” You can read the NBC story here.
All Federally Qualified Health Centers and FQHC look-alikes are invited to apply for the Spring 2021 cohort TransECHO program. TransECHO uses the ECHO case-based learning model to engage health systems in collaborating to improve health care for transgender and gender-diverse patients. Each monthly session includes a didactic presentation and case studies presented for group consultation.
TransECHO is a free program and CME credits are available.
“Screening, Counseling, and Shared Decision Making for Alcohol Use with Transgender and Gender-Diverse Populations” was recently published in the journal LGBT Health. Authored by Director of Education and Training Programs, Dr. Alex S. Keuroghlian and Jacob Arellano-Anderson, this article discusses how current alcohol screening tools and guidelines do not distinguish between sex- and gender-related characteristics.
An editorial published in The British Journal of Psychiatry calls for the development of alternative psychiatric care frameworks that affirm transgender and gender-diverse (TGD) people without pathologizing them through clinical diagnoses. The editorial was authored by researchers at The Fenway Institute and Dartmouth-Hitchcock Medical Center and adds to a growing body of literature demonstrating the need to uncouple gender diversity from the stigma of diagnostic classification.
Advancing Excellence in Transgender Health was developed in response to the high volume of queries from clinicians and health care staff seeking to learn about providing high-quality care for adults, adolescents, and children who are questioning their gender identity or who identify as transgender or gender-diverse.
A Call for Gender Identity Data Collection in iPLEDGE and Increasing the Number of Isotretinoin Prescribers Among Transgender Health Providers, authored by Sean Singer and Alex Keuroghlian, MD, MPH, highlights that incorporating gender identity based questions in iPLEDGE registration documents would increase information about gender-diverse patients taking isotretinoin, the most effective medication for severe recalcitrant acne, and allow better understanding of teratogenicity risks among these patients. An increase in the number of transgender health providers registered as isotretinoin prescribers in iPLEDGE would increase access to this effective medicine and may improve outcomes in trans-masculine people with severe acne.
Dr. Alex Keuroghlian, Director of Education and Training Programs, is interviewed in this new Healio article titled "Pediatricians play ‘critical’ role in care of transgender youths."
The National LGBT Health Education Center is excited to announce the following upcoming live webinars in April.
Details and registration information are provided by clicking "Read More." CMEs are available.
Date/Time: Thursday, April 23, 2020 2:00-3:00pm EDT
Faculty: Janet Barbieri, MSW, LICSW, Director of Training and Education at the Asperger/Autism Network of New England (AANE); Kendrick, Neurodiversity Advocate and AANE Speaker's Bureau Panelist; Dr. Alex Keuroghlian, Director of the Division of Education and Training at The Fenway Institute, Psychiatrist at Fenway Health, Associate Professor of Psychiatry at Harvard Medical School
This webinar will address the intersectionality of LGBTQIA+ identity and neurodiversity. Dr. Alex Keuroghlian will discuss psycho-social implications for people who are sexual and gender minorities and also neurodiverse, and also discuss how to best serve these individuals. Janet Barbieri will address social supports for LGBTQIA+ and neurodiverse people and the importance of community opportunities and engagement for these individuals. AANE Speaker's Bureau panelist Kendrick will describe his experience as an LGBTQIA+ and neurodiverse person, and talk about what he needs from his healthcare providers and his community.
Date/Time: Wednesday, April 29, 2020 1:00-2:00pm EDT
Faculty: Kenneth H. Mayer, MD, Infectious Disease Attending and Director of HIV Prevention Research Beth Israel Deaconess Medical Center Professor of Medicine, Harvard Medical School Medical Research Director, The Fenway Institute
In this webinar, Dr. Ken Mayer will address telePrEP and the PrEP at home model for LGBTQIA+ patients. Dr. Mayer will cover the basics of starting and monitoring PrEP with an at-home start, and also address specific needs and concerns for sexual and gender minority people around PrEP and telePrEP.
The Fenway Institute has partnered with the Patient-Centered Outcomes Research Institute (PCORI) to inform clinicians and transgender women about the results of a recent PCORI-funded study on heart health when using estrogen.